Melissa Watson

Doctor of Osteopathic Medicine,  Toronto General - University Health Network 

Location: Africa

Consulting Services

Scientific Writing Career Advice and Mentoring Admin and Customer Support Research Consulting Pharma-CRO-Device

Areas Of Interest

alpha-1 Lipoprotein Sensory Deprivation Cyclic AMP-Dependent Protein Kinase Type II Nucleotidylexotransferase, DNA Infections, Ascaris Colicin Plasmid Isoenzymes Pyloric Glands Neoplasms, Endocrine Gland Receptors, AH Bombs Relaxed Stretching Lingual Nerve Public Assistance Idoxuridine, 123I-Labeled Alpine Tundra Plastic Cast Melanocyte-Stimulating Hormone, beta Pneumococcal Vaccines Isovinculin Schools, Health Occupations Chlorisondamine Chloride Nucleus Striae Terminali HDL2, Lipoprotein Type II Arnold Chiari Malformation MAP1 Microtubule-Associated Protein Nerve-Muscle Preparations Colony Forming Units Assay, Microbial Thistles, Red Star Reflex Sympathetic Dystrophy Pseudogene CYP3A7 Inhibitors Levobupivacaine Genes, Hox Guanylin Uroguanylin Receptors CELSS Tracings, Neuronal Pathway Cell, BALB-c 3T3 Selenate, Disodium

Professional Narrative

Dr. Melissa Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Harvard Med 2013
Senior Director, Amgen 2000

Education

Bachelor of science in nursing, Weill Medical College 1987
Director Medicine, Harvard Medical School 2003

Referees


Publications

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :